Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2026-05-23 @ 12:05 PM
Study NCT ID:
NCT06006403
Status:
RECRUITING
Last Update Posted:
2023-08-30
First Post:
2023-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm
Sponsor:
Chongqing Precision Biotech Co., Ltd
Organization: